Galderma Laboratories has agreed to a $990K settlement to resolve the class action lawsuit that alleged certain Differin acne products contained benzene, a known carcinogen
Galderma Laboratories has agreed to a $990K settlement to resolve the class action lawsuit that alleged certain Differin acne products contained benzene, a known carcinogen
www.classaction.org
Certain Differin Acne Treatments Contain Toxic Carcinogen Benzene, Class Action Alleges
A class action alleges Galderma has failed to warn consumers that some of its Differin acne cream products potentially contain a dangerous carcinogen.
